Reply to "Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?"

Affiliations

¹ Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
² Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
³ Department of Radiation Oncology, Erasmus University MC Cancer Institute, Rotterdam, The Netherlands.
⁴ Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

Free article

Comment

Berthe M P Aleman et al. Cancer. 2023.

Free article

. 2023 May 1;129(9):1455-1456.

doi: 10.1002/cncr.34713. Epub 2023 Feb 24.

¹ Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
² Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
³ Department of Radiation Oncology, Erasmus University MC Cancer Institute, Rotterdam, The Netherlands.
⁴ Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.

No abstract available

Comment on

Breast cancer and cardiovascular outcomes after breast cancer in survivors of Hodgkin lymphoma.
Krul IM, Boekel NB, Kramer I, Janus CPM, Krol ADG, Nijziel MR, Zijlstra JM, van der Maazen RWM, Roesink JM, Jacobse JN, Schaapveld M, Schmidt MK, Opstal-van Winden AWJ, Sonke GS, Russell NS, Aleman BMP, van Leeuwen FE. Krul IM, et al. Cancer. 2022 Dec 15;128(24):4285-4295. doi: 10.1002/cncr.34464. Epub 2022 Oct 25. Cancer. 2022. PMID: 36281718
Can we avoid thoracic radiotherapy in young females with Hodgkin lymphoma?
Chakrabarti D, Brahma Bhatt ML. Chakrabarti D, et al. Cancer. 2023 May 1;129(9):1453-1454. doi: 10.1002/cncr.34712. Epub 2023 Feb 24. Cancer. 2023. PMID: 36827439 No abstract available.